Table: Immuno Biological Lab -Q1 group results

Immuno-Biological Laboratories

07/08/2023 07:30

Aug 7 (Reuters)- 
             Immuno Biological Laboratories Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            177 mln             156 mln          850 mln   
                 (+13.3 pct)         (+25.0 pct)      (+7.0 pct)  
  Operating         0 mln            loss 14 mln        90 mln    
                                                      (+54.2 pct) 
  Recurring        13 mln            loss 54 mln        90 mln    
  Net              11 mln            loss 58 mln        80 mln    
  EPS             1.19 yen          loss 6.32 yen      8.58 yen   
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Immuno Biological Laboratories Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T